IVD Medical (HKG:1931) said it plans to list its shares in the U.S. and flagged an expected decrease in its H1 profit, according to a Hong Kong bourse filing Monday.
Shares of the medical equipment seller rose nearly 7% in morning trade Tuesday.
The company plans to list American depositary shares on the Nasdaq market in the U.S., though the proposal is at an early stage and requires that certain conditions be met, IVD Medical said.
Meanwhile, the company expects to report at least 33 million yuan in attributable profit for the six months ended June 30, compared to a profit of 125 million yuan in the comparable period last year.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。